Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases

NCT02650752 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Central Nervous System (CNS) Metastases

Interventions

DRUG: Lapatinib in Tandem With Capecitabine

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]